Bridge Prescription for Albuterol and Budesonide in Urgent Care
For an adult patient with asthma and allergies presenting to urgent care, prescribe albuterol 2.5 mg nebulizer solution every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed, and budesonide 0.5 mg nebulizer suspension twice daily as a bridge prescription. 1
Albuterol Dosing
For acute symptom relief in adults:
- Initial treatment: 2.5-5 mg via nebulizer every 20 minutes for 3 doses 1
- Maintenance: 2.5-10 mg every 1-4 hours as needed 1
- Alternatively, if using MDI: 4-8 puffs every 20 minutes up to 4 hours, then every 1-4 hours as needed 1
Write the prescription for: Albuterol 2.5 mg/3 mL nebulizer vials, dispense 30-60 vials, use 2.5-5 mg every 4-6 hours as needed for wheezing or shortness of breath.
Budesonide Dosing
For controller therapy as a bridge:
- Adults not previously on inhaled corticosteroids: Start with 0.5 mg once daily or 0.25 mg twice daily 2
- Adults previously on inhaled corticosteroids: 0.5 mg twice daily (up to 1 mg total daily dose) 2
Write the prescription for: Budesonide 0.5 mg/2 mL nebulizer suspension, dispense 60 vials (30-day supply), use 0.5 mg twice daily via nebulizer.
Key Clinical Considerations
Important caveats:
- Budesonide is FDA-approved for children 12 months to 8 years of age 2, but the dosing principles apply to adults in clinical practice
- The combination approach addresses both bronchoconstriction (albuterol) and inflammation (budesonide) 3, 4
- Recent evidence shows as-needed albuterol-budesonide combination reduces severe exacerbations by 47-53% compared to albuterol alone 3, 4
For patients with moderate-to-severe asthma: Consider the newer FDA-approved fixed-dose combination albuterol-budesonide 180/160 µg MDI (2 actuations = 1 dose) as needed, which has been shown to reduce exacerbation risk by 26% 4. However, this requires a specific prescription for the combination product.
Ensure follow-up: Patients should be instructed to follow up with their primary care provider or pulmonologist within 3-7 days to establish long-term controller therapy, as this is a bridge prescription only. The budesonide provides anti-inflammatory coverage while awaiting definitive asthma management 5.